1 study found for:    NCT01585805
Show Display Options
Rank Status Study
1 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: veliparib;   Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years